What sector does NeuroSense Therapeutics Ltd. Warrant (NRSNW) operate in?
NeuroSense Therapeutics Ltd. Warrant belongs to the Healthcare sector and operates in the industry.
What is NeuroSense Therapeutics Ltd. Warrant (NRSNW) current stock price?
As of the latest data, NeuroSense Therapeutics Ltd. Warrant stock price is $0.16, with a previous close of $0.19. NeuroSense Therapeutics Ltd. Warrant lost -$0.03 in the last trading session, representing a -13.93% loss.
What is NeuroSense Therapeutics Ltd. Warrant (NRSNW) current market capitalization?
NeuroSense Therapeutics Ltd. Warrant market cap is approximately 5.21 million.
What is NeuroSense Therapeutics Ltd. Warrant (NRSNW) Earnings Per Share (EPS)?
The trailing EPS is -$0.94.
Does NeuroSense Therapeutics Ltd. Warrant (NRSNW) pay dividends?
No. NeuroSense Therapeutics Ltd. Warrant does not pay a dividend.
What is NeuroSense Therapeutics Ltd. Warrant (NRSNW) beta (volatility) score?
NeuroSense Therapeutics Ltd. Warrant has a beta of 1.678, suggesting it is more volatile than the market.